Stamford, CTNCT07091019Now EnrollingIRB Ready

Chronic Myelogenous Leukemia - Chronic Phase Clinical Trial in Stamford, CT

Access cutting-edge chronic myelogenous leukemia - chronic phase treatment through this clinical trial at a research site in Stamford. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Stamford location

Preparing your pre-screening questions…

Expert Care in Stamford

Access chronic myelogenous leukemia - chronic phase specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic myelogenous leukemia - chronic phase treatment provided free

Apply for This Stamford Location

Check if you qualify for this chronic myelogenous leukemia - chronic phase clinical trial in Stamford, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Stamford

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Stamford site if eligible
  4. 4Begin participation

About This Chronic Myelogenous Leukemia - Chronic Phase Study in Stamford

This CML disease registry (ASC4REAL-2) aims to gather evidence on the tolerability, safety, effectiveness, and patient-reported outcomes (PRO) in real-world healthcare from patients with Ph+-CML-CP treated with TKIs approved for 1L and 2L, including prospective follow-up for 5 years identifying and describing long-term treatment outcomes.

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

18 years or older at the time of Ph+-CML-CP diagnosis.
Receiving TKI treatment (asciminib, bosutinib, dasatinib, imatinib, or nilotinib) in routine medical care either as initial therapy or after 1 prior TKI therapy.
Receiving treatment at US and US territories (i.e., Puerto Rico) medical practice (e.g. community-based, office-based, hospital-based, academic).
Signed informed consent form (ICF) prior to participation in the study including agreement to be tokenized so that the patient's anonymized RWD (EMRs and/or claims data) can be accessed.

Exclusion Criteria

Active participation in an interventional trial that may influence the management of their Ph+-CML-CP disease.
Currently being treated with a CML TKI in 3L or beyond.
Known presence of T315I mutation.
Currently in TFR phase and are not on active CML TKI therapy.
Previously received treatment with a prior stem cell transplant
Pregnant or nursing (lactating) female.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Stamford?

Yes, this clinical trial (NCT07091019) has an active research site in Stamford, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Myelogenous Leukemia - Chronic Phase Treatment Options in Stamford, CT

If you're searching for chronic myelogenous leukemia - chronic phase treatment options in Stamford, CT, this clinical trial (NCT07091019) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Stamford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic myelogenous leukemia - chronic phase specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic myelogenous leukemia - chronic phase clinical trials near you to find additional studies recruiting in your area.

Ready to Join in Stamford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Stamford, CT